Transvenous pacemaker lead extraction in infective endocarditis

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 511-513

  Calvagna, Giuseppe Mario ^a   Patanè, Salvatore ^a  

^a Cardiologia Ospedale San Vincenzo   (Italy)

Author keywords

Endocarditis; Extraction; Implantable defibrillator; Lead; Pacemaker

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; DAPTOMYCIN; HEMOGLOBIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; CASE REPORT; DEVICE REMOVAL; ECHOCARDIOGRAPHY; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LETTER; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; NONHUMAN; PACEMAKER IMPLANTATION; SEPSIS; STAPHYLOCOCCUS AUREUS; SUBCLAVIAN VEIN; TISSUE NECROSIS; TRANSVENOUS PACEMAKER LEAD EXTRACTION; TRICUSPID VALVE; VERY ELDERLY; ENDOCARDITIS, BACTERIAL; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGY; PREVENTION AND CONTROL;

AGED, 80 AND OVER; ENDOCARDITIS, BACTERIAL; EQUIPMENT CONTAMINATION; HUMANS; MALE; PACEMAKER, ARTIFICIAL;

EID: 84922397689     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.049     Document Type: Article

References (93)

1. Calvagna GM, Patanè S. Severe Staphylococcal Sepsis in patient with permanent pacemaker. Int J Cardiol Apr 1 2014; 172(3): E498-501.
2. Ward C, Henderson S, Metcalfe NH. A short history on pacemakers. Int J Cardiol Nov 15 2013; 169(4): 244-8.
3. Schulman PM, Rozner MA, Sera V, Stecker EC. Patients with pacemaker or implantable cardioverter-defibrillator. Med Clin North Am Nov 2013; 97(6): 1051-75 [Review].
4. Toutouzas K, Synetos A, Tousoulis D, et al. Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: The role of a new echocardiographic index. Int J Cardiol Apr 1 2014; 172(3): 601-3.
5. Giugno V, Messina F, Crosca S. Treatment failure of low molecular weight heparin bridging therapy after implantation of a permanent pacemaker. Int J Cardiol May 15 2014; 173(3): E23-4.
6. Joung YH. Development of implantable medical devices: From an engineering perspective. Int Neurourol J Sep 2013; 17(3): 98-106 [Review].
7. Aizawa Y, Takatsuki S, Negishi M, et al. Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy. Int J Cardiol Apr 1 2014; 172(3): E529-30.
8. Scarano M, Pezzuoli F, Torrisi G, Calvagna GM, Patanè S. Cardiovascular implantable electronic devices infective endocarditis. Int J Cardiol 2014 May 15; 173(3): E38-9.
9. Ahmed S, Ungprasert P, Srivali N, Ratanapo S, Cheungpasitporn W, Chongnarungsin D. Lead perforation: An uncommon cause of chest pain in a patient with pacemaker. Int J Cardiol Sep 1 2013; 167(5): E113-4.
10. Van Galen KP, van Dijk J, Regelink JC, Huijgens PC, Minnema MC, Zweegman S. Implantable defibrillators in cardiac amyloidosis. Int J Cardiol May 10 2013; 165(2): 371-3.
11. Fang F, Zhang Q, Chan JY, et al. Early pacing-induced systolic dyssynchrony is a strong predictor of left ventricular adverse remodeling: Analysis from the Pacing to Avoid Cardiac Enlargement (PACE) trial. Int J Cardiol Sep 30 2013; 168(2): 723-8.
12. Sairaku A, Yoshida Y, Nakano Y, Kihara Y. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation. Int J Cardiol Oct 15 2013; 168(6): 5273-6.
13. Fang F, Chan JY, Lee AP, et al. Improved coronary artery blood flow following the correction of systolic dyssynchrony with cardiac resynchronization therapy. Int J Cardiol Sep 1 2013; 167(5): 2167-71.
14. Cheng Z, Deng H, Cheng K, Chen T, Gao P, Fang Q. Implantation of a pacemaker in a patient with persistent left superior vena cava and absence of right superior vena cava. Int J Cardiol Sep 30 2013; 168(2): E53-4.
15. Schukro C, Leitner L, Siebermair J, et al. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy. Int J Cardiol Sep 10 2013; 167(6): 3006-10.
16. Gatzoulis KA, Tsiachris D, Dilaveris P, et al. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work? Int J Cardiol Aug 20 2013; 167(4): 1360-5.
17. Peyrol M, Sbragia P, Obadia B, et al. The safety of cardiac resynchronization therapy pacemaker implantation in octogenarians: A monocentric experience. Int J Cardiol Oct 3 2013; 168(3): 2969-70.
18. Sankaranarayanan R, Visweswariah R, Fox DJ. New developments in cardiac resynchronization therapy. Br J Hosp Med (Lond) Sep 2013; 74(9): 503-9 [Review].
19. Patanè S. Paced patient and acute myocardial infarction. Int J Cardiol Nov 1 2012; 161(1): E16-7.
20. Veselka J, Krejcí J, Tomašov P, et al. Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block. Int J Cardiol Feb 1 2014; 171(2): E37-8.
21. La Rocca R, Materia V, Falliano MF, Sciacca N, Marte F, Patanè S. Hyperkalaemic cardiac arrhythmia with pacemaker/implantable cardioverter-defibrillator action disturbance. Int J Cardiol May 3 2012; 156(3): E49-50.
22. Udo EO, van Hemel NM, Zuithoff NP, et al. Long term quality-of-life in patients with bradycardia pacemaker implantation. Int J Cardiol Oct 3 2013; 168(3): 2159-63.
23. Calvagna GM, Ceresa F, Patanè S. Subcutaneous implantable cardioverter-defibrillator in a young woman. Int J Cardiol 2014 Aug 1; 175(2): E30-2.
24. Reinke F, Löher A, Köbe J, Eckardt L. Current status and problems of the entirely subcutaneous ICD (S-ICD®). Herzschrittmacherther Elektrophysiol Sep 2013; 24(3): 165-70 [German].
25. Aziz S, Leon AR, El-Chami MF. The subcutaneous defibrillator-A review of the literature. J Am Coll Cardiol 2014 Apr 22; 63(15): 1473-9.
26. Calvagna GM. Recall, malfunzionamenti e infezioni in portatori di PM/ICD.Possono condizionare le scelte clinico-interventistiche e la qualità della vita? GIAC 2010; 13(3-4): 217-22.
27. Scarano M, Pezzuoli F, Patanè S. Brucella infective endocarditis. Int J Cardiol Apr 1 2014; 172(3): E509-10.
28. Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures? J Cardiovasc Transl Res Apr 2014; 7(3): 369-71.
29. Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy? J Cardiovasc Transl Res Apr 2014; 7(3): 372-4.
30. Calvagna GM. Progressivo malfunzionamento di elettrocatetere da stimolazione cardiaca permanente secondario a processo infettivo asintomatico. GIAC 2012; 15(1): 51-4.
31. Calvagna GM, Curatolo S, La Greca S, Evola R. Sepsi Stafilococciche in pazienti portatori di PM e\o ICD: Dal trattamento antibiotico all'intervento di Rimozione Transvenosa Manuale. G Ital Arit e Cardiostim, vol. 13, n.11; Marzo 2010.
32. Patanè S. A dark side of the cardio-oncology: The bacterial endocarditis prophylaxis. Int J Cardiol Jun 14 2012; 157(3): 448-9.
33. Calvagna GM, Mangano A, Evola R. Infezioni su estremita' distali degli elettrocateteri da stimolazione cardiaca permanente rimossi mediante tecnica transvenosa manuale: Casistica dal 2002 al 2007 presso centro unico dedicato. G. Ital. Aritm. e Cardiostim, 4; 2008. p. 65-8.
34. Imai A, Gotoh K, Asano Y, et al. Comprehensive metagenomic approach for detecting causative microorganisms in culture-negative infective endocarditis. Int J Cardiol Mar 15 2014; 172(2): E288-9.
35. Cholteesupachai J, Franzen O, Søndergaard L. Transcatheter aortic valve implantation in a patient with severe native aortic regurgitation after infective endocarditis. Int J Cardiol Mar 1 2014; 172(1): E187-9.
36. Finsterer J, Dumser M. Noncompaction in a septic heart, missed on echocardiography. Int J Cardiol Feb 15 2014; 171(3): E70-1.
37. Cheung G, Vejlstrup N, Ihlemann N, et al. Infective endocarditis following percutaneous pulmonary valve replacement: Diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol Nov 30 2013; 169(6): 425-9.
38. Lu KJ, Kearney LG, Ord M, Jones E, Burrell LM, Srivastava PM. Age adjusted Charlson Co-morbidity Index is an independent predictor ofmortality over longterm follow-up in infective endocarditis . Int J Cardiol Oct 15 2013; 168(6): 5243-8.
39. Bassetti M, Righi E, Crapis M, et al. Gentamicin once-daily in enterococcal endocarditis. Int J Cardiol Oct 12 2013; 168(5): 5033-4.
40. Chatterjee S, Sardar P. Early surgery reduces mortality in patients with infective endocarditis: Insight from a meta-analysis. Int J Cardiol Oct 3 2013; 168(3): 3094-7.
41. Citro R, Mirra M, Baldi C, et al. Concomitant dynamic obstruction and endocarditis after "valve in valve" TAVI implantation. Int J Cardiol Jul 31 2013; 167(2): E27-9.
42. Tharayil A, Fernando R, Bungo MW. An unusual case of endocarditis. Int J Cardiol Jun 5 2013; 166(1): E21-2.
43. Ratanapo S, Ungprasert P, Permpalung N, CheungpasitpornW, Chongnarungsin D. The increasing incidence of Streptococcus bovis endocarditis: A New York dairy farmer with epidural abscess. Int J Cardiol Jun 20 2013; 166(2): E35.
44. Loyens M, Thuny F, Grisoli D, et al. Link between endocarditis on porcine bioprosthetic valves and allergy to pork. Int J Cardiol Jul 31 2013; 167(2): 600-2.
45. Liu A, Nicol E, Hu Y, Coates A. Tuberculous endocarditis. Int J Cardiol Aug 10 2013; 167(3): 640-5.
46. Ostrowski S, Kasielski M, Kordiak J, Zwolinska A, Wlodarczyk A, Nowak D. Myocardial oxidative stress in patients with active infective endocarditis. Int J Cardiol Jul 15 2013; 167(1): 270-6.
47. Grabowski M, Hryniewiecki T, Stepinska J. Novel markers of cerebral embolism in the course of infective endocarditis. Int J Cardiol Jan 12 2012; 154(1): 90-2.
48. Rodríguez-Bailón I, Carrasco-Chinchilla F, Ruiz-Salas A, et al. Right atriumvegetation in prosthetic aortic endocarditis. Int J Cardiol May 3 2012; 156(3): 335-6.
49. El Hajjaji I, Mansencal N, Dubourg O. Diagnosis of Cardiobacterium hominis endocarditis: Usefulness of positron emission tomography. Int J Cardiol Sep 20 2012; 160(1): E3-4.
50. Stöllberger C, Bonner E, Finsterer J. Enterococcus faecalis bacteremia and mitral valve endocarditis under dabigatran for stroke prevention. Int J Cardiol 2014 Jul 1; 174(3): 836-8.
51. Bhattacharyya S, Bahrami T, Rahman-Haley S. Comprehensive assessment of complications of infective endocarditis by 3D transesophageal echocardiography. Int J Cardiol 2014 Jul 1; 174(3): E87-9.
52. Pugliatti P, De Gregorio C, Patanè S. The chance finding of echocardiographic complications of infective endocarditis. Int J Cardiol 2012 Nov 29; 161(3): E50-1.
53. Thanavaro KL, Nixon JV. Endocarditis 2014: An update. Heart Lung 2014 July -August; 43(4): 334-7.
54. Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol Sep 30 2013; 168(2): 648-52.
55. Chikata A, Omi W, Saeki T, Nagai H, Sakagami S. Repeated pacemaker dysfunction in a patient with recurrent takotsubo cardiomyopathy precipitated by hyponatremia. Int J Cardiol Jan 1 2014; 170(3): 443-4.
56. Kawata H, Patel J, McGarry T, et al. Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation. Int J Cardiol Apr 1 2014; 172(3): E522-4.
57. Calvagna GM, Evola R. Complicanze non infettive o malfunzionamenti in pazienti portatori di PM e/o ICD: Importanza della rimozione transvenosa. G. Ital. Aritm e Cardiostim, 12(2); 2009. p. 69-78.
58. Calvagna GM, Patanè S, Romeo P, Ceresa F, Sansone F, Patanè F. Embolization and retrieval of an anchoring sleeve during transvenous lead extraction. Int J Cardiol May 15 2014; 173(3): E42-4.
59. Calvagna GM, Foti R, Lisi M, Evola R. Rimozione transvenosa manuale di elettrocateteri da Pacemaker e\o ICD malfunzionanti o infetti mediante tecnica transvenosa manuale: Esperienza di unico centro regionale dedicato (anni 2002-2007). G. Italian. Aritm. e Cadiostim, 4; 2007. p. 30-5.
60. Calvagna GM, Evola R, Scardace G, Valsecchi S. Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace Nov 2009; 11(11): 1505-9.
61. Calvagna GM, Evola R, Scardace G, Valsecchi S. Successful removal of a jugular implantable defibrillator lead with mechanical single-sheath technique. Pacing Clin Electrophysiol Sep 2012; 35(9): E258-60.
62. Calvagna GM, Evola R, Valsecchi S. A complication of pacemaker lead extraction: Pulmonary embolization of an electrode fragment. Europace 2010; 12: 613.
63. Calvagna GM, Romeo P, Ceresa F, Valsecchi S. Transvenous retrieval of foreign objects lost during cardiac device implantation or revision: A 10-year experience. Pacing Clin Electrophysiol Jul 2013; 36(7): 892-7.
64. Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Procedure-and device-related complications and psychological morbidity in implantable cardioverter defibrillator patients. Int J Cardiol Sep 20 2013; 168(1): 606-7.
65. Feola M, Vallauri P, Salvatico L, Vado A, Testa M. Neuropsychological impact of implantable cardioverter defibrillator in congestive heart failure patients. Int J Cardiol Jun 5 2013; 166(1): 275-6.
66. Denollet J, Tekle FB, Pedersen SS, van der Voort PH, Alings M, van den Broek KC. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator. Int J Cardiol Sep 10 2013; 167(6): 2705-9.
67. Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. Int J Cardiol Jun 5 2013; 166(1): 215-20.
68. Ingles J, Sarina T, Kasparian N, Semsarian C. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol Oct 9 2013; 168(4): 3779-84.
69. van den Broek KC, Tekle FB, Habibovic M, Alings M, van der Voort PH, Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int J Cardiol May 10 2013; 165(2): 327-32.
70. Calvagna GM, Torrisi G, Giuffrida C, Patanè S. Pacemaker, Implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life. Int J Cardiol 2014 Jun 15; 174(2): 378-80.
71. Pugliatti P, Donato R, Di Bella G, Carerj S, Patanè S. Contrast-enhancing right atrial thrombus in cancer patient. Int J Cardiol May 15 2014; 173(3): E35-7.
72. Pugliatti P, Donato R, Zito C, Carerj S, Patanè S. Cardio inhibitory vasovagal syncope in a cancer patient. Int J Cardiol 2014 Jun 15; 174(2): E64-5.
73. Patanè S. Cardiotoxicity: Cisplatin and long term cancer survivors. Int J Cardiol 2014 Jul 15; 175(1): 201-2.
74. Patanè S. A challenge in cardiology: The oncosurgery. Int J Cardiol 2014 Jun 15; 174(2): 411-2.
75. Patanè S. Heart failure and breast cancer: Emerging controversies regarding some cardioprotective strategies. J Card Fail 2014 Jun; 20(6): 456-7.
76. Escárcega RO, Magalhaes MA, Lipinski MJ, et al. Mortality in patients requiring pacemaker implantation following transcatheter aortic valve replacement: Insights from a systematic review and meta-analysis. Int J Cardiol 2014 Jun 1; 174(1): 207-8.
77. Kusumoto S, Kawano H, Makita N, et al. Right bundle branch block without overt heart disease predicts higher risk of pacemaker implantation: The study of atomic-bomb survivors. Int J Cardiol 2014 Jun 1; 174(1): 77-82.
78. Steinfurt J, Biermann J, Hartmann M, et al. Remote ICD-monitoring in detection and follow-up of triggers of idiopathic ventricular fibrillation: Implications for the clinical management of IVF patients. Int J Cardiol 2014 Jun 15; 174(2): E29-31.
79. Viswanathan K, Lewis N, Pepper C. An unusual defibrillator lead complication identified at explant. Int J Cardiol 2014 Jun 15; 174(2): E66-7.
80. Inciardi RM, Rotolo A, Coppola G, et al. Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art. Int J Cardiol 2014 Jun 1; 174(1): 191-2.
81. Schuchert A, Muto C, Maounis T, et al. MASCOT study group. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Europace Jan 2013; 15(1): 71-6.
82. Deckx S, Marynissen T, Rega F, et al. Predictors of 30-day and 1-year mortality after transvenous lead extraction: A single-centre experience. Europace Feb 25 2014; 16(8): 1218-25.
83. Rodriguez Y, Garisto J, Carrillo RG.Management of cardiac device-related infections: A review of protocol-driven care. Int J Cardiol Jun 5 2013; 166(1): 55-60 [Review].
84. Cho H, Kim M, Uhm JS, Pak HN, Lee MH, Joung B. Transvenous pacemaker lead removal in pacemaker lead endocarditis with large vegetations: A report of two cases. Korean Circ J Mar 2014; 44(2): 118-21.
85. Singh N, Langer V, Chadha DS, et al. Percutaneous removal of transvenous pacemaker leads using an extraction device. Med J Armed Forces India Jul 2013; 69(3): 291-3.
86. Brunner MP, Cronin EM, Duarte VE, et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm May 2014; 11(5): 799-805.
87. Brunner MP, Cronin EM, Wazni O, et al. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm Mar 2014; 11(3): 419-25.
88. Cronin EM, Brunner MP, Tan CD, et al. Incidence, management, and outcomes of the arteriovenous fistula complicating transvenous lead extraction. Heart Rhythm Mar 2014; 11(3): 404-11.
89. Maciag A, Syska P, Przybylski A, et al. The effectiveness of transvenous leads extractions implanted more than 10 years ago. Cardiol J Mar 27 2014, doi: 10.5603/ CJ.a2013.0143.
90. Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: High success rate and safety in more than 2000 leads. Eur Heart J 2008; 29: 2886-93.
91. Polewczyk A, Janion M, Podlaski R, Kutarski A. Clinical manifestations of leaddependent infective endocarditis: Analysis of 414 cases. Eur J Clin Microbiol Infect Dis May 3 2014; 33(9): 1601-8.
92. Maseda E, Mensa J, Valía JC, et al. Bugs, hosts and ICU environment: Countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting. Rev Esp Quimioter Dec 2013; 26(4): 312-31.
93. Sohal M, Williams SE, Arujuna A, et al. The current practice and perception of cardiac implantable electronic device transvenous lead extraction in the UK. Europace Jun 2013; 15(6): 865-70.